Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Liddicoat B"'
Autor:
Zlotorynski, Eytan
Publikováno v:
Nature Reviews Molecular Cell Biology. Sep2015, Vol. 16 Issue 9, p518-518. 1p.
Publikováno v:
In International Journal of Obstetric Anesthesia May 2023 54 Supplement 1
Autor:
Guirguis AA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Ofir-Rosenfeld Y; Storm Therapeutics Ltd, Cambridge, United Kingdom., Knezevic K; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Blackaby W; Storm Therapeutics Ltd, Cambridge, United Kingdom., Hardick D; Storm Therapeutics Ltd, Cambridge, United Kingdom., Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Motazedian A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Gillespie A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Vassiliadis D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Tran K; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Andrews B; Storm Therapeutics Ltd, Cambridge, United Kingdom., Harbour ME; Storm Therapeutics Ltd, Cambridge, United Kingdom., Vasiliauskaite L; Storm Therapeutics Ltd, Cambridge, United Kingdom., Saunders CJ; Storm Therapeutics Ltd, Cambridge, United Kingdom., Tsagkogeorga G; Storm Therapeutics Ltd, Cambridge, United Kingdom.; Milner Therapeutics Institute, University of Cambridge, Cambridge, United Kingdom., Azevedo A; Storm Therapeutics Ltd, Cambridge, United Kingdom., Obacz J; Storm Therapeutics Ltd, Cambridge, United Kingdom., Pilka ES; Evotec (UK) Ltd, Abingdon, United Kingdom., Carkill M; Charles River Laboratories, Portishead, United -Kingdom., MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Wainwright EN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Liddicoat B; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Blyth BJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Albertella MR; Storm Therapeutics Ltd, Cambridge, United Kingdom., Rausch O; Storm Therapeutics Ltd, Cambridge, United Kingdom., Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, -Victoria, Australia.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Oct 05; Vol. 13 (10), pp. 2228-2247.
Autor:
Garciaz S; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France., Guirguis AA; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Müller S; Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Paris, France., Brown FC; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Chan YC; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Motazedian A; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Rowe CL; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Kuzich JA; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Chan KL; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Tran K; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Smith L; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., MacPherson L; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Liddicoat B; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lam EYN; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Cañeque T; Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Paris, France., Burr ML; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Litalien V; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Pomilio G; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Poplineau M; Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France., Duprez E; Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France., Dawson SJ; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Ramm G; Monash Ramaciotti Centre for Cryo Electron Microscopy, Monash University, Melbourne, Victoria, Australia., Cox AG; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia., Brown KK; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia., Huang DCS; The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., McArthur K; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Rodriguez R; Institut Curie, PSL Research University, CNRS UMR3666, INSERM U1143, Chemical Biology of Cancer, Paris, France., Dawson MA; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Mar 01; Vol. 12 (3), pp. 774-791.
Autor:
Fink EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., McConkey M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Adams DN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Haldar SD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Kennedy JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA.; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada; and., Guirguis AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Udeshi ND; Proteomics Platform, Broad Institute, Cambridge, MA., Mani DR; Proteomics Platform, Broad Institute, Cambridge, MA., Chen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Liddicoat B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Svinkina T; Proteomics Platform, Broad Institute, Cambridge, MA., Nguyen AT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA., Carr SA; Proteomics Platform, Broad Institute, Cambridge, MA., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Hematology, Division of Medicine, Brigham and Women's Hospital, Boston, MA.; Cancer Program, Broad Institute, Cambridge, MA.
Publikováno v:
Blood [Blood] 2018 Oct 04; Vol. 132 (14), pp. 1535-1544. Date of Electronic Publication: 2018 Jul 31.
Autor:
Vorderbruggen, Makenzie1,2 (AUTHOR) mvorderbruggen@unmc.edu, Velázquez-Martínez, Carlos A.3 (AUTHOR) velazque@ualberta.ca, Natarajan, Amarnath1,2 (AUTHOR) anatarajan@unmc.edu, Karpf, Adam R.1,2 (AUTHOR) adam.karpf@unmc.edu
Publikováno v:
International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5067. 15p.
Autor:
Vasileva, Radina1 radina.vasileva@trakia-uni.bg, Chaprazov, Tsvetan1
Publikováno v:
Open Veterinary Journal. 2024, Vol. 14 Issue 4, p1012-1018. 7p.
Autor:
de Reuver R; VIB-UGent Center for Inflammation Research, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Maelfait J; VIB-UGent Center for Inflammation Research, Ghent, Belgium. jonathan.maelfait@irc.vib-ugent.be.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. jonathan.maelfait@irc.vib-ugent.be.
Publikováno v:
Nature reviews. Immunology [Nat Rev Immunol] 2024 Apr; Vol. 24 (4), pp. 235-249. Date of Electronic Publication: 2023 Sep 26.
Publikováno v:
Biomedicines; Nov2024, Vol. 12 Issue 11, p2451, 27p
Autor:
Thomas, Ruth C, Zaksauskaite, Ringaile, Al-Kandari, Norah Y, Hyde, Anne Cathrine, Abugable, Arwa A, El-Khamisy, Sherif F, van Eeden, Freek J
Publikováno v:
Nucleic Acids Research; 10/14/2024, Vol. 52 Issue 18, p11014-11028, 15p